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Abstract
Aedes aegypti, the mosquito vector of dengue viruses, utilizes its innate immune system to ward off a variety of pathogens,
some of which can cause disease in humans. To date, the features of insects’ innate immune defenses against viruses have
mainly been studied in the fruit fly Drosophila melanogaster, which appears to utilize different immune pathways against
different types of viruses, in addition to an RNA interference–based defense system. We have used the recently released
whole-genome sequence of the Ae. aegypti mosquito, in combination with high-throughput gene expression and RNA
interference (RNAi)-based reverse genetic analyses, to characterize its response to dengue virus infection in different body
compartments. We have further addressed the impact of the mosquito’s endogenous microbial flora on virus infection. Our
findings indicate a significant role for the Toll pathway in regulating resistance to dengue virus, as indicated by an infection-
responsive regulation and functional assessment of several Toll pathway–associated genes. We have also shown that the
mosquito’s natural microbiota play a role in modulating the dengue virus infection, possibly through basal-level stimulation
of the Toll immune pathway.
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Introduction
The dengue viruses, whose geographic distribution resembles
that of malaria, has become the most important arboviral
pathogen in recent years because of its increasing incidence in
the tropics and subtropics as well as its high morbidity and
mortality. The public health impact of dengue is enormous, given
that 2.5 billion people live in dengue-endemic areas and are at
daily risk of infection [1]. The dengue viruses are single-stranded
positive RNA belonging to the family Flaviviridae, genus Flavivirus.
They are transmitted between humans primarily by the mosquito
Ae. aegypti and by Ae. albopictus as a secondary vector [2]. The four
closely related dengue serotypes are antigenically distinct, each
comprising several genotypes that exhibit differences in their
infection characteristics in both the mosquito vector and the
human host [3,4].
The extrinsic incubation period of dengue viruses in the
mosquito is 7–14 days and is dependent on the mosquito strain,
virus genotype, and environmental factors such as humidity and
temperature [5,6]. When the mosquito ingests a dengue-infected
blood meal, the virus first infects the midgut tissue, within which it
replicates to produce more virus particles. It then spreads through
the hemolymph to other tissues such as the trachea, fat body, and
salivary glands, where it is further propagated through replication.
Peak virus titers usually occur between 7 and 10 days post-
infection in the midgut and between 7 and 17 days in the
abdomen. Peak levels in the head and salivary gland occur later, at
about 12–18 days after feeding [7]. This extrinsic incubation time
varies for different virus-vector combinations, and the tropism of
the virus is dependent on the mosquito’s tissue- and cell-specific
susceptibility to different genotypes [5,7].
In arthropods, innate immunity plays an important role in
limiting pathogen infection, both through the production of
effector molecules such as antimicrobial peptides and through
phagocytosis and encapsulation, secretion of physical barriers, and
melanization [8]. Studies that were mainly conducted in the insect
model D. melanogaster have shown that arthropod immune
responses are largely regulated by two main pathways, the Toll
and immune deficiency (Imd) pathways [9,10].
Activation of the Toll pathway by microbes through pattern
recognition receptors (PRRs) leads to a cascade of events that
result in the degradation of the negative regulator Cactus,
translocation to the nucleus of transcription factors such as Dif,
and a rapid increase in antimicrobial compounds and other
effectors [10–12]. The Imd pathway is involved in the defense
against Gram-negative bacteria, and upon activation it follows a
cascade of events similar to those in the Toll pathway, involving
putative degradation of its negative regulator Caspar, translocation
of the transcription factor Relish to the nucleus, and the
production of effectors and antimicrobial compounds [13,14]. In
contrast to the relatively well-characterized Toll and Imd
pathways, less is known about the Janus kinase signal transducers
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comprises multiple factors and has been linked to immune
responses in the fruit fly [15,16]. Comparative genomics analyses
have shown a striking degree of conservation of these immune
signaling pathways in D. melanogaster, Anopheles gambiae and Ae.
aegypti; in contrast, the upstream pattern recognition receptors and
the downstream effectors have differentiated quite significantly
among the three species, probably as a result of different microbial
exposures [17].
The Rel family transcription factors, Dif and Relish in
Drosophila or their corresponding Rel1 and Rel2 in mosquitoes,
can be studied through RNA interference (RNAi)-mediated
silencing of the negative regulators Cactus and Caspar, respec-
tively [11,13,14]. This approach allows a transient simulation, to
at least a partial degree, of the Toll and Imd pathways in the
absence of a microbial elicitor. The activation of these pathways
can be monitored through the transcriptional activation of some of
the signal cascade factors, such as the up-regulation of the Rel
family transcription factors and down-regulation of the negative
regulator Cactus or Caspar for the Toll or Imd pathway,
respectively [11,13,14].
At present, relatively little is known about the anti-viral defense
systems in insects. In D. melanogaster, the RNAi-mediated defenses
appear to be key players in the defense against a broad range of
viruses [18,19], while some of the classical innate immune
pathways such as the Toll and JAK-STAT pathways have also
been implicated in limiting virus infection [20,21]. Specifically, D.
melanogaster has been shown to use its RNAi machinery and the
Toll pathway to limit Drosophila6virus infection (a member of the
Dicistroviridae) [19,21], and it uses its RNAi machinery and the
JAK-Stat pathway to limit Drosophila C virus infection (a member
of the Birnavirus family) [20,22]. Another study has demonstrated
the involvement of the D. melanogaster RNAi machinery in the
defense against two diverse animal viruses: a flock house virus and
a cricket paralysis virus [18]. With all the above knowledge,
however, the molecular mechanisms that govern their activation
after infection and their role in virus clearance are unknown. Links
between the RNAi machinery and the innate immune signaling
pathways have yet not been identified [18,23].
Similarly, limited knowledge on the antiviral response in
mosquitoes is available. In Ae. aegypti, Sindbis virus (Alphavirus;
Togaviridae) infection has been shown to induce the Toll pathway-
related Rel1 transcription factor and three transcripts of the
ubiquitin-ligase pathway genes, which are known regulators of
NFkB-like proteins [24]. The RNAi machinery has also been
linked to the anti-dengue defense in Ae. aegypti [25] and anti-
O’nyong-nyong virus (Alphavirus; Togaviridae)i nAn. gambiae [26]. In
addition, the O’nyong-nyong virus has been shown to induce 18
genes in A. gambiae, including a 70-kDa heat shock protein factor
that later was shown to influence the virus’s ability to propagate in
the vector [27].
The recently available Ae. aegypti genome sequence [28], in
combination with high-throughput gene expression and reverse
genetic methodology, have provided unprecedented opportunities
to study the mosquito’s responses and defenses against dengue
virus infection. Here, we report the global transcriptional response
of Ae. aegypti to the infection of dengue virus serotype 2 (DENV-2),
and show that DENV-2 induces a set of genes corresponding to
the Toll and JAK-STAT pathways. Activation of the Toll and Imd
pathways in Ae. aegypti through RNAi-mediated silencing of Cactus
and Caspar caused a reduction in dengue virus infection level that
appeared to be controlled primarily by the Toll pathway.
Repression of the Toll pathway through MYD88 gene silencing
resulted in higher dengue virus infection levels. We also present
compelling evidence for an inhibitory effect of the mosquito’s
natural microbiota on virus infection and discuss the implications
of these findings and the potential role of the mosquito’s microbial
exposure and innate immune system in modulating dengue virus
transmission.
Results
Global transcriptome responses to dengue infection at
10 days after an infected blood meal
We first assessed the physiological response of the Ae. aegypti
mosquito to systemic dengue infection at the gene-specific level in
the midgut and remaining carcass by using a genome-wide
transcriptional profiling approach. A comparison of the transcript
abundance in the two body compartments of mosquitoes that were
fed 10 days earlier on dengue-infected blood or naı ¨ve blood
revealed broad responses to virus infection that entailed a variety
of physiological systems (Fig 1). The carcass displayed a
significantly larger number of regulated genes (240 up-regulated
and 192 down-regulated) than did the smaller midgut tissue (28
up-regulated and 35 down-regulated). The magnitude of the gene
regulation, as measured by the -fold change in transcript
abundance, was also greater in the carcass, suggesting that tissues
in the carcass are at this stage of infection more actively engaged in
the response to infection, while the midgut tissue may have
reached a steady-state/balance in its interaction with the virus
(Tables S1 and S2). A fairly large proportion (33.5%) of the genes
displayed a similar expression profile in the midgut and the carcass
(Tables 1, S1, and S2). The most striking infection-responsive gene
regulation was observed for genes with putative functions related
to the mosquito’s innate immune system; these genes represented
34.5% in the midgut and 27.5% in the carcass of all the regulated
genes with predicted functions (Fig. 1). Other major functional
gene groups that were affected by virus infection included
metabolism, oxidoreductive processes, and stress responsive
systems, and are discussed in greater detail in Text S1.
Immune responses to dengue infection
The 53 and 18 putative immune genes that were regulated by
virus infection in the carcass and midgut tissues, respectively, were
associated with a variety of immune functions such as PRRs,
signaling modulation and transduction, effector systems, and
apoptosis (Table 1). The functional group representations of the
infection-responsive genes and their direction of regulation in the
carcass and midgut tissues were quite similar, suggesting that the
Author Summary
The Aedes aegypti mosquito is largely responsible for the
transmission of dengue viruses that cause disease in
humans. The virus is taken up with an infected blood meal
from which it will first infect the mosquito gut tissue. From
the gut it will migrate to other parts of the mosquito,
including the salivary glands, from where it can be
transmitted to another human upon a second blood meal.
In this study we show that the mosquito utilizes its innate
immune system to control dengue virus infection.
Infection with the virus will result in the activation of
mosquito immune responses that are mainly controlled by
the Toll pathway. These responses entail antiviral activities
that limit infection with the virus. We also show that the
mosquito’s natural microbial flora play a role in modulat-
ing the dengue virus infection, possibly through the
stimulation of the mosquito’s immune system.
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nisms in these two compartments. For example, specific genes that
displayed a similar pattern of regulation were lysozyme C (LYSC,
AAEL015404), gambicin (AAEL004522), Ikkg (AAEL012510) and
the Gram-negative binding protein A2 (GNBPA2, AAEL000652).
A closer investigation of immune gene regulation using in silico
comparative genomics analysis [17] revealed a striking bias toward
genes putatively linked with the Toll immune signaling pathway
(Fig. 2) as well as the JAK-STAT pathway. Activation of the Toll
pathway in the carcass was supported by the up-regulation of
Spaetzle (Spz), Toll, and Rel1A, and the down-regulation of the
negative regulator Cactus. Three members of the Gram-negative
bacteria-binding protein (GNBP) family were up-regulated,
together with a clip-domain serine protease (CLIP), while the
other two CLIPs were down-regulated; several antimicrobial
effector molecules were up-regulated, including the defensins
(DEFs), cecropins (CECs) and a lysozyme (LYSC). Only one
predicted gene of the Imd immune signaling pathway, Ikkg, was
down-regulated. One of the key components of the JAK-STAT
pathway, Domeless (Dome), was induced upon dengue virus
infection as well as three other genes (AAEL009645, AAEL009822
and AAEL000393) which have JAK-STAT pathway related
orthologs in D. melanogaster [29]. Six members of the thio-ester
containing protein (TEPs) gene family were also regulated by
dengue infection, while TEP1 has been demonstrated to be a
down-stream effector molecule of JAK-STAT pathway in D.
melanogaster [30].
To establish further evidence that dengue infection activates the
Toll immune signaling pathway, we designed experiments to assess
the relationships between dengue infection-responsive gene
regulation and Rel1- and Rel2-controlled gene regulation.
Previous studies in D. melanogaster and An. gambiae have shown that
the Rel1 and Rel2 transcription factors can be activated by
depleting their negative regulators Cactus and Caspar, respectively
[13,14,31]. To confirm that the Toll and Imd pathway had been
activated, we depleted Cactus and Caspar using RNAi silencing
and assayed the expression of the antimicrobial peptide genes DEF
and CEC in gene-silenced mosquitoes and non-silenced controls
(Fig. 3A). Gene silencing of either Cactus or Caspar induced the
expression of these two genes. To link this activation to the Rel1
and Rel2 transcription factors, we performed double-knockdown
assays in which both Cactus and Rel1 or Caspar and Rel2 were
targeted simultaneously with RNAi and compared the effect of this
double silencing on antimicrobial peptide gene expression to that
of silencing the negative regulators alone. The double-knockdown
treatments either compromised (in the case of Cactus and Rel1) or
completely reversed (in the case of Caspar and Rel2) the effect
induced by single-knockdown of Cactus or Caspar, respectively,
indicating that these negative regulators could be used to activate
these two transcription factors (Fig. 3A). The quantitative
differences in the levels of de-activation of the Rel1- and Rel2-
controlled transcription that were produced with this double-
knockdown approach most likely reflect differences in the
efficiency and kinetics of the RNAi-mediated depletion of different
proteins.
We then determined the gene repertoires that were regulated by
the Rel1 and Rel2 transcription factors, using a microarray-based
approach in which we compared the transcript abundance in the
Cactus and Caspar gene-silenced mosquitoes to that in GFP
dsRNA-treated control mosquitoes. Our results indicated that
differential gene regulation in the Cactus-depleted mosquitoes
showed a strong bias toward the Toll pathway. For instance, we
observed the up-regulation of Rel1 (AAEL007696), multiple Toll
receptors (AAEL007619, AAEL000057, AAEL007613), Spa ¨tzle
ligands (AAEL013434, AAEL008596), Gram-negative binding
proteins (AAEL007626 and AAEL003889), and the antimicrobial
peptides DEFD, CECA, D, E & G (AAEL003857, AAEL000627,
AAEL000598, AAEL000611, AAEL015515). In total, Cactus
gene silencing resulted in the up-regulation of 460 and down-
regulation of 1423 genes belonging to different functional classes,
with a predominant representation by immune genes (13.7% of all
genes with predicted functions). The regulation of a variety of
other functional gene groups by Rel1 is indicative of the multiple
functional roles of the Toll pathway, including its contributions to
immunity and development [32].
Differential gene regulation in Caspar-depleted mosquitoes was
much less pronounced, with only 35 genes being induced and 137
being repressed. Those induced by Caspar silencing included
TEP13 and the antimicrobial peptides DEFE and gambicin
(AAEL004522 and AAEL003849). Rel1 and Rel2 are most likely
regulating additional genes that were not detected because of the
limited sensitivity of microarray-based gene expression assays.
A comparison of the dengue infection-responsive gene reper-
toire to that of Cactus gene-silenced mosquitoes showed a
significant overlap, with 41% (18 of 44) of the immune genes
being up-regulated by both the virus infection and Cactus gene
silencing (Fig. 3B). In contrast, only 9% (4 of 44) of the dengue-
regulated immune genes were also regulated in Caspar gene-
silenced mosquitoes (Fig. 3B). Hierarchical clustering of genes that
Figure 1. Functional classification of differentially expressed
genes in the dengue-infected midgut and carcass at 10 days
after blood meal. The graph shows the functional class distributions
in real numbers of genes that are regulated by virus infection (+
indicate induced and – indicate repressed). The virus infection
responsive gene expression data are presented in Tables S1 and S2.
Functional group abbreviations: IMM, immunity; R/S/M, redox, stress
and mitochondrion; CSR, chemosensory reception; DIG, blood and
sugar food digestive; PRT, proteolysis; C/S, cytoskeletal and structural;
TRP, transport; R/T/T, replication, transcription, and translation; MET,
metabolism; DIV, diverse functions; UNK, unknown functions.
doi:10.1371/journal.ppat.1000098.g001
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of Cactus- and Caspar-silenced mosquitoes.
Gene ID Gene Name No Function group Logfold
Carcass Midgut dsCact dsCaspar
AAEL000709 CACT 62 Toll 20.842 20.084 0.515 0.074
AAEL007696 REL1A 64 Toll 0.924 20.096 1.005 0.157
AAEL001929 SPZ5 63 Toll 1.61 0.037 0.034 0.106
AAEL003507 TOLL1B 66 Toll 0.947 0.014 0.08
AAEL013441 TOLL9A 65 Toll 1.189 20.036 20.054 0.149
AAEL004223 CECB 5 Effector 0.544 0.81 20.148 0.61
AAEL015515 CECG 6 Effector 1.052 0.131 1.394 22.992
AAEL003832 DEFC 9 Effecttor 21.81 0.143 0.95 21.665
AAEL003857 DEFD 8 Effector 20.127 1.076 0.999 21.962
AAEL003849 DEFE 7 Effector 0.824 0.053 20.811 1.697
AAEL004522 GAM 10 Effector 0.851 1.118 21.406 0.85
AAEL015404 LYSC 11 Effector 1.007 0.935 1.105 0.082
AAEL006702 FREP 31 Pattern Recognition Receptor 1.143 0.031 20.333 20.009
AAEL006699 FREP 32 Pattern Recognition Receptor 21.129 21.297 0.016
AAEL006704 FREP 33 Pattern Recognition Receptor 0.073 20.896 21.128 0.313
AAEL000652 GNBPA2 28 Pattern Recognition Receptor 0.805 0.928 0.041 20.025
AAEL009178 GNBPB4 30 Pattern Recognition Receptor 0.92 20.126 20.065 0.061
AAEL007064 GNBPB6 29 Pattern Recognition Receptor 0.886 0.088 0.118 21.077
AAEL003325 ML 34 Pattern Recognition Receptor 20.949 0.85 0.05 0.083
AAEL009531 ML 35 Pattern Recognition Receptor 1.427 20.072 0.031 20.83
AAEL006854 ML 36 Pattern Recognition Receptor 0.031 1.143 0.263 0.219
AAEL014989 PGPPLD, putative 38 Pattern Recognition Receptor 2.11 0.101 20.155 20.113
AAEL011608 PGRPLD 37 Pattern Recognition Receptor 1.962 0.011 20.098 20.099
AAEL012267 TEP13 41 Pattern Recognition Receptor 1.325 0.084 0.112 0.8
AAEL014755 TEP15 42 Pattern Recognition Receptor 1.19 20.023 1.628 0.168
AAEL001794 TEP20 40 Pattern Recognition Receptor 0.896 0.191 1.518 0.313
AAEL000087 TEP22 39 Pattern Recognition Receptor 1.819 0.084 1.896 0.317
Aaeg:N19306 TEP24 44 Pattern Recognition Receptor 0.8943
Aaeg:N18111 TEP25 43 Pattern Recognition Receptor 1.2427
AAEL003253 CLIPB13B 45 Signal Modulation 1.038 0.209 1.638 0.003
AAEL005093 CLIPB46 48 Signal Modulation 20.913 1.121 0.344
AAEL005064 CLIPB5 46 Signal Modulation 20.852 0.059 1.548 0.315
AAEL007593 CLIPC2 47 Signal Modulation 20.815 0.15 1.379 0.155
AAEL014390 CTL 52 Signal Modulation 0.986 0.162 0.942 0.188
AAEL003119 CTL6 49 Signal Modulation 0.85 0.018 0.12 20.009
AAEL011619 CTLGA8 51 Signal Modulation 0.986 0.085 1.129 0.281
AAEL011455 CTLMA12 50 Signal Modulation 1.095 0.134 2.473 0.216
AAEL000256 SCRB9 53 Signal Modulation 1.036 0.203 0.223 0.023
AAEL014079 SRPN1 59 Signal Modulation 0.915 20.017 0.995 20.027
AAEL007765 SRPN10A 61 Signal Modulation 0.166 20.963 0.841 20.009
AAEL014078 SRPN2 58 Signal Modulation 0.884 20.048 22.026
AAEL002730 SRPN21 54 Signal Modulation 1.426 0.128 0.41 0.148
AAEL002715 SRPN22 60 Signal Modulation 0.12 1.244 0.062 0.166
AAEL013936 SRPN4A 57 Signal Modulation 1.35 0.041 1.426 0.156
AAEL013934 SRPN4D 56 Signal Modulation 1.343 0.217 0.91 0.259
AAEL008364 SRPN9 55 Signal Modulation 20.951 20.031 1.275 0.169
AAEL000393 Suppressors of cytokine signalling 13 JAK-STAT 0.909 0.058 0.186 0.103
AAEL009645 Hypothetical protein 14 JAK-STAT 20.846 20.584 0.427 20.012
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(Cactus silencing, Caspar silencing, and dengue infection) revealed
a close relationship between Cactus silencing- and dengue
infection-related regulation (Fig. 3C). In particular, expression
cluster V, which is highly enriched with immune genes, was
affected by both the Cactus silencing and dengue infection
treatments. Differential gene expression in Cactus-silenced and
dengue-infected mosquitoes showed a strong correlation with
regard to both the direction and magnitude of the regulation of
this expression cluster (Fig. 3C, Cluster V).
Further dissection of the expression cluster V defined three
main groups: Toll pathway-, JAK-STAT pathway-, and signal
modulation- related genes. The signal modulation cascade genes
included four C-type lectins (CTLs) and six serine protease
inhibitors (SRPNs). A plausible hypothesis is that both the Toll and
JAK-STAT pathways may be regulated at least in part by the
same signal modulation cascade that includes serine proteases and
serpins. Consistent to this hypothesis, evidences suggest that the
JAK-STAT pathway could be indirectly activated by the Toll
cascade in D. melanogaster [30]. Interestingly, genes in this cluster
showed similar regulation for the midgut and carcass and for
Cactus-silenced mosquitoes, although the magnitude of the
regulation was smaller in the midgut, further supporting the
notion of a similar type of antiviral defense in the gut and carcass
tissues. Expression cluster III was characterized by a repression of
seven oxidative defense enzyme genes in both Cactus-silenced and
dengue-infected mosquitoes (Fig3C, Cluster III). The genes that
showed different profiles for Cactus silencing and dengue infection
are listed in the remaining clusters (Fig 3C, Cluster I, II and IV).
Several putative apoptotic genes, such as caspases, were also
regulated by dengue infection. Similar results have also been
observed in D. melanogaster in response to Drosophila C virus
infection [20], suggesting a potential connection between virus
infection and apoptosis.
The Toll pathway is involved in the anti-dengue defense
The prominent activation of the Toll pathway (Rel1)-regulated
genes in response to dengue infection strongly suggested that this
pathway is involved in the mosquito’s anti-dengue defense. To
investigate this hypothesis, we tested the effect of both Cactus and
Caspar gene silencing on virus infection in the midgut and carcass
at 7 days after an infectious blood meal. This cactus gene silencing
reduced the extent of dengue infection in the midgut by 4.0-fold
(P,0.05), while Caspar gene silencing had no effect on viral
infection when compared to the GFP dsRNA control (Fig. 4). The
lower viral loads in the midguts of mosquitoes treated with Cactus
dsRNA were also confirmed by IFA assay (Fig. 4). To provide
further evidence for Toll pathway implication in controlling
dengue virus infection, we assessed whether loss of Toll pathway
activation will lead to an increase in virus load. The Toll pathway
was inactivated by silencing the MYD88 factor prior to dengue
virus titer determination [33]. This resulted in an increase of the
virus load by 2.7 times compared to the GFP dsRNA control
(P,0.001). Infection levels in the carcass tissue were generally very
low for all treatment groups, and there were no significant
differences between groups. These results point to a significant role
for the Toll pathway in the anti-dengue defense in the midgut
tissue and they are similar to those reported for D. melanogaster,i n
which the Toll pathway, but not the Imd pathway, has been
shown to be involved in limiting X-virus infection. Together with
the gene expression data discussed above, our results suggest that
the infection of mosquitoes with dengue virus induces the Toll
pathway, which then exerts an anti-dengue effect.
Gene ID Gene Name No Function group Logfold
Carcass Midgut dsCact dsCaspar
AAEL009822 Metabotropic glutamate receptor 15 JAK-STAT 1.405 0.185 20.086 0.028
AAEL012471 DOME 16 JAK-STAT 1.078 20.06 1.561 20.868
AAEL012510 IKK2 12 Imd 20.912 21.042 0.043 20.034
AAEL003439 CASPS18 1 Apoptosis 0.803 0.017 20.821 20.094
AAEL012143 CASPS7 2 Apoptosis 20.854 0.014 20.068 20.034
AAEL011562 CASPL2 3 Apoptosis 20.606 20.839 0.183 0.076
AAEL014658 CASPS20 4 Apoptosis 20.898 20.064 0.019
Aaeg:N41501 CAT1A 17 Oxidative defense enzymes 20.84617
AAEL004386 HPX8C 18 Oxidative defense enzymes 21.106 20.031 21.745 0.049
AAEL004388 HPX8A 19 Oxidative defense enzymes 21.685 0.047 22.054 0.094
AAEL004390 HPX8B 20 Oxidative defense enzymes 21.034 0.063 21.357 0.268
AAEL000274 CuSOD3, putative 21 Oxidative defense enzymes 20.911 20.119 21.184 0.078
AAEL006271 CuSOD2 22 Oxidative defense enzymes 20.841 20.006 21.099 20.001
AAEL009436 SOD-Cu-Zn 23 Oxidative defense enzymes 20.955 20.473 0.173 0.148
AAEL011498 CuSOD3 24 Oxidative defense enzymes 20.9 20.16 21.205 0.079
AAEL004112 TPX2 25 Oxidative defense enzymes 21.433 20.265 20.84 0.06
AAEL014548 TPX3 26 Oxidative defense enzymes 20.893 0.021 20.17 20.041
AAEL002309 TPX4 27 Oxidative defense enzymes 20.301 21.486 0.13 0.153
Dengue-infected midguts and carcasses were dissected and collected from the mosquitoes at 10 day after the blood meal. Injection of dsRNA of Cactus and Caspar into
mosquitoes was conducted at 2 days post-emergence, and samples were collected for microarray analysis at 4 days after injection.
doi:10.1371/journal.ppat.1000098.t001
Table 1. Cont.
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dengue infection
The mosquito’s innate immune system is mainly involved in the
defense against microbes, including control of the mosquito’s
natural bacterial flora [34], which have also been shown to
influence the mosquito’s susceptibility to pathogens such as
malaria [35,36] and are responsible for a certain level of basal
level activation of immune signaling pathways (Dimopoulos lab,
unpublished data). In order to assess the potential influence of the
endogenous bacterial flora of Ae. aegypti on the mosquito’s immune
gene expression and susceptibility to dengue virus infection, we
compared transcription and infection levels between normal septic
mosquitoes and mosquitoes from which the bacterial flora had
been eliminated through antibiotic treatment (Fig. 5). The virus
titer in the midguts of antibiotic-treated mosquitoes was two times
higher than that in the non-treated mosquitoes at 7 days PBM
(Fig. 5C and 5D).
This antiviral effect could reflect either a direct interaction
between the bacteria and the virus in the midgut lumen or an
indirect effect involving a bacteria-elicited basal level of immune
activation. To investigate whether the endogenous bacteria flora
had the capacity to activate genes regulated by the Toll pathway,
we compared the expression levels of 11 selected immune genes,
including several antimicrobial peptide genes, in septic and
antibiotic-treated aseptic mosquitoes. This analysis showed an
elevated expression of several immune marker genes, including the
Toll pathway-regulated antimicrobial peptide genes defensin,
cecropin, attacin, and gambicin, in the septic mosquitoes,
suggesting that the endogenous bacterial flora were stimulating
immune gene expression (Fig. 5B). In order to determine whether
the midgut bacteria could exert a direct effect on the virus in the
midgut lumen, we assayed virus viability after a 3 hrs incubation in
the lumenal blood meals of septic and antibiotic-treated aseptic
mosquitoes. In a parallel assay, we assessed the loss of virus
viability after 4 hrs incubation in vitro with the enriched bacteria
derived from mosquito midguts. These assays did not show any
influence of the bacteria on virus viability (Figure S1), suggesting
that the effect of the mosquito’s endogenous bacterial flora on
dengue virus infection was indirect and likely to be mediated by
the mosquito’s innate immune system.
Discussion
In order to dissect the Ae. aegypti mosquito responses to dengue
virus infection, we have determined the changes in the midgut and
carcass transcriptomes that occur upon systemic virus infection at
10 days after an infectious blood meal. These responses involved a
variety of functional gene classes, indicating a significant impact of
virus infection on mosquito physiology. The broader and stronger
response in the carcass is probably related to the late stage of
infection when the virus has reached its peak level in the tissues of
this compartment; at the same time, infection of the midgut is
declining. This analysis revealed a strong bias in the transcrip-
tional response toward genes that have been linked to the Toll
immune pathway, and to a lesser extent the JAK-STAT immune
pathway, whereas genes putatively linked to the Imd immune
pathway seemed to be largely unaffected. A more detailed
comparison of the dengue virus infection-responsive transcriptome
and the putative Rel1- and Rel2-regulated transcriptomes further
corroborated this finding.
The activation of the Toll immune signaling pathway by dengue
infection is strongly supported by the up-regulation of Rel1 and
several of its upstream putative PRRs and its downstream
antimicrobial peptides (Fig. 2). Up-regulation of the Ae. aegypti
Rel1 (DR081921) has also been observed in response to Sindbis
virus infection in a previous study [24], suggesting that these
viruses may induce similar responses. In D. melanogaster, infection
with either the Drosophila6virus or E. coli has been shown to induce
the same antimicrobial peptide genes, suggesting that these two
diverse classes of pathogen can activate the same immune response
pathway [21]. Infection of D. melanogaster with the Drosophila C virus
also resulted in the up-regulation of several putative Toll pathway-
related genes, such as Spa ¨tzle, Dorsal, the immune induced
molecule 2, CG16836, PGRP-SA, a GNBP-like molecule encoded
by CG12780, Drosomycin, and nine other putative antimicrobial
peptides [20]. Both PGRP-SA and GNBPs have been linked to the
Toll immune signaling pathway; a D. melanogaster GNBP functions
as a co-receptor for Gram-positive bacteria and is involved in Toll
immune pathway activation. It will be interesting to elucidate the
Figure 2. Regulation of putative Toll signaling pathway genes
by dengue virus infection. Red color indicates infection responsive
up-regulation and green color indicate infection responsive down-
regulation. Non-colored gene boxes indicate lack of infection respon-
sive regulation. The pathway was built with GenMapp software based
on the immunogenomics prediction by Waterhouse et al 2007.
doi:10.1371/journal.ppat.1000098.g002
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response to dengue infection in Ae. aegypti. For instance, the
GNBPs might function as receptors that interact with the virus or
cellular debris released during virus particle release, either
activating an immune response or directly neutralizing the virus
particles.
Activation of Toll pathway-controlled Rel1 transcription factors
through the RNAi-mediated depletion of Cactus resulted in
suppression of the viral infection in the midgut, while activation of
the Imd pathway-controlled Rel2, mediated through Caspar
depletion, had no effect on infection. Although Rel1 over-
expressing transgenic mosquitoes have been developed, we chose
to use this RNAi-based approach to activate these factors in order
to achieve systemic pathway activation and enrichment of immune
factors prior to infection. The Rel1 transgenes are under the
control of a blood meal-induced fatbody-specific promoter that
only activates transcription at around 12 to 20 h after a blood
meal in a very specific tissue compartment, which may not be the
main destination for the dengue virus (A. Raikhel, personal
communication) [31].
The lack of an apparent link between the Imd pathway and the
anti-dengue defense at 7 to 10 days after an infectious blood meal
does not, however, exclude the possibility that this pathway is
involved in the anti-viral response at some other stage of infection
or in a specific tissue or cell type. However, our results are
consistent with the previous report that the Toll pathway, but not
the Imd pathway, in D. melanogaster is involved in the defense
against the Drosophila X virus [21]. The anti-dengue effect of the
Toll pathway is likely to be stronger than the four-fold change that
we obtained through Cactus gene silencing, given that RNAi-
mediated depletion of proteins is known to be incomplete and
transient in many cases.
Our gene expression data also pointed to an activation of the
less characterized JAK-STAT pathway, which has been shown to
be activated in response to Drosophila C virus infection in D.
melanogaster, where it is involved in limiting viral infection but,
while required, is not sufficient to mount a potent antiviral
response [20]. These findings may suggest that an effective anti-
viral response in insects requires the activation of more than one
complementary defense system.
Figure 3. Comparative analysis of the dengue virus infection-responsive and Rel1 and Rel2 regulated transcriptomes. A. Expression
analysis of defensin (DEF), cecropin (CEC), Cactus (CAC), and Rel1 in Cactus, and Cactus and Rel1 depleted mosquitoes (upper panel) and in Caspar,
and Caspar and Rel2 depleted mosquitoes. Bar represents standard error. B. Venn diagram showing uniquely and commonly regulated genes in
dengue infected and Cactus and Caspar depleted mosquitoes. C. Cluster analysis of 131 genes that were regulated in at least two of four treatments:
dengue-infected midgut and carcass, and whole mosquitoes upon Cactus (CAC(-)) or Caspar (CSP(-)) depletion. The expression data of immune
genes, indicated by the number beside the panel are presented in Table 1, and all genes presented in the hierarchical cluster matrix are listed in Table
S6. The primary data for the real-time qPCR assays are presented in Table S3.
doi:10.1371/journal.ppat.1000098.g003
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in D. melanogaster: an inducible response that involves the activation
of immune signaling pathways and an intrinsic defense system
based on RNAi [23]. Our analysis of dengue infection-responsive
gene expression did not identify any RNAi-related genes,
consistent with the previous findings regarding D. melanogaster
responses to Drosophila C virus infection [20]. Components of the
RNAi defense systems are likely to be constitutively expressed and
do therefore not require further transcriptional induction upon
viral challenge. Alternatively, the virus may actively suppress
transcription of such transcripts as a defense modulating
mechanism.
A major role of immune signaling pathways in insects is to
protect the organism against the continuous exposure to
opportunistic microbes as well as controlling the natural
microbiota, such as the gut flora. Several studies have shown the
importance of the host microbiota in inducing a basal level of
immune activity that enhances the insect’s resistance to pathogens.
For instance, antibiotic treatment of An. gambiae mosquitoes
significantly reduces the microbial midgut flora, resulting in a
decreased expression of immune genes and an increased
susceptibility to Plasmodium infection [35,36]. Moreover, Plasmodi-
um development has recently been shown to be significantly
influenced by the mosquito’s basal level immunity rather than an
infection-stimulated induction of immune genes [13]. In addition,
the An. gambiae genes implicated in the defense against Plasmodium
have also been shown to play a role in its anti-bacterial defense
[34]. In Culex. bitaeniorhynchus, tetracycline treatment resulted in an
increased susceptibility to the Japanese encephalitis virus [37].
Similarly, we have observed that aseptic Ae. aegypti were less
resistant to dengue virus, and they expressed lower levels of certain
immune genes that are also controlled by the Toll pathway.
These findings suggest that it is plausible to hypothesize that the
mosquito’s endogenous microbiota and natural microbial expo-
sure stimulate a certain level of immune gene expression through
the activation of the Toll pathway which, in turn, mediates
antiviral activity. Alternatively, the microbiota could affect viral
infection in a more direct way by altering the biochemical
environment of the midgut or by directly interacting with the virus
particles. However, the latter is not supported by our preliminary
data on virus-bacteria interaction, while a possibility still exist that
the bacteria hinder virus interaction with the midgut epithelium
(Figure S1). Regardless of their biological basis, however, our
results suggest that the microbial exposure in nature is likely to
play an important role in modulating the mosquito’s anti-viral
defense system and its level of resistance to infection. The ability of
the Toll immune pathway to suppress dengue infection suggests
that it regulates one or several anti-viral effector molecules that
remain to be discovered. The level of functional overlap that was
observed between anti-bacterial and anti-Plasmodium effector genes
in A. gambiae is unlikely to occur between the anti-microbial and
anti-dengue defense systems because of the drastically difference in
surface molecules and life style between virus particles and
bacteria or parasites; nevertheless, the defenses appear to be
regulated by the same immune signaling pathways. Finally, it is
unlikely that the presence of low levels of antibiotics in the
mosquito hemolymph contributed directly to changes in gene
expression or increased virus infection. Antibiotic treatment has
for instance no effect on virus propagation in the C6/36 cell line,
and experiments in sterile A. gambiae mosquito cell lines have not
shown any direct effects of antibiotic treatment on immune gene
expression (Dimopoulos lab, unpublished data).
In summary, the results presented here show that the Toll
pathway is involved in controlling dengue virus infection in Ae.
aegypti. Dengue infection can activate this pathway, which in turn
induces a mechanism that suppresses the virus infection.
Consistent with this observation, a low basal immunity in aseptic
mosquitoes is correlated with a high virus infection level. Our
results provide support for future experiments to dissect the
biological network involved in the defense against dengue virus
infection in Ae. aegypti. For example, it will be interesting to study
the potential links between the Toll, JAK-STAT and RNAi
pathways and their relevant contribution to the resistance of
dengue infection in mosquitoes. In addition, how the virus is
recognized to activate the Toll pathway and what are the
downstream anti-viral effector molecules are important questions
to be answered. In the present study, we have utilized a specific
New Guinea genotype of the DENV-2 serotype that is known to
Figure 4. Rel1 regulate anti-dengue activity. Dengue virus loads in the midguts of Cactus, Caspar and MyD88 depleted mosquitoes, and GFP
dsRNA treated control mosquitoes. A. Virus titers were measured by plaque assay in C6/36 cell. *, P,0.05, ***, P,0.001, in Student’s t-test comparing
to GFP control. B. Virus load is assayed through indirect immunofluorescence assay (IFA) in infected midguts. Error bar represents standard error.
doi:10.1371/journal.ppat.1000098.g004
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similarities and differences in the response of the mosquito to
different dengue virus serotypes and genotypes that are known to
differ in their virulence and tropism. Conversely, a comparison of
mosquito strains with different susceptibilities to a particular virus
genotype may also further our understanding of this complex
vector-pathogen system.
In summary, we demonstrate a significant role of the Toll
pathway in regulating resistance to dengue virus in Ae. aegypti,a s
indicated by an infection-responsive regulation and functional
assessment of several Toll pathway-associated genes. We have also
shown that the mosquito’s natural microbiota play a role in
modulating the dengue virus infection, possibly through basal-level
stimulation of the mosquito’s antiviral immune system.
Materials and Methods
Mosquito rearing and cell culture maintenance
Ae. aegypti mosquitoes of the Rockefeller/UGAL strain were
maintained on sugar solution at 27uC and 95% humidity with a
12-hr light/dark cycle according to standard rearing procedures.
The Ae. albopictus cell line C6/36 was grown in minimal essential
medium (MEM) with 10% heat inactivated FBS, 1% L-glutamine,
and 1% non-essential amino acids at 32uC with 5% CO2.
DENV-2 infections
The New Guinea C strain of DENV-2 was propagated in C6/
36 cells according to standard conditions [38]: In brief, 0.5 ml
aliquots of virus stock were used to infect 75-cm
2 flasks of C6/36
cells at 80% confluency with a multiplicity of infection (MOI) of
3.5 virus particles/cell. Infected cells were incubated for 5–7 days.
Cells were harvested with a cell scraper and lysed to release the
virus particles by repeated freezing and thawing in dry CO2 and a
37uC water bath. The virus suspension was mixed 1:1 with
commercial human blood. A flask with uninfected C6/36 cells
were maintained under similar conditions and used to create the
noninfectious blood meal that served as our control. The blood
meal was maintained at 37uC for 30 min prior to feeding 3- to 4-
day-old mosquitoes (http://www.jove.com/index/Details.stp?ID
=220). Primary PFU data are presented in Table S4.
Mosquito dissections
For microarray assays, mosquitoes at 10 days after blood meal
were dissected to collect the midguts and carcass in RNALater,
with 10 to 15 individuals in a single replicate. Three or four
replicate biological assays were performed. Total RNA was
extracted using the RNeasy kit (QIAGEN), and RNA concentra-
tions were measured using Nanodrop; for virus titer measurement,
mosquitoes at 7 days after blood meal were briefly washed in 70%
ethanol, then rinsed in sterile distilled water. The midgut and
carcass were dissected in sterile PBS and transferred separately to
microcentrifuge tubes containing 150 ml of MEM, then homog-
enized with a Kontes pellet pestle motor in a sterile environment.
Microarray assays
Transcription assays were conducted and analyzed as reported
previously with a full genome Agilent-based microarray platform
[28,34] In brief, 2–3 mg total RNA was used for probe synthesis of
cy3- and cy5-labeled dCTP. Hybridizations were conducted with
an Agilent Technologies In Situ Hybridization kit at 60uC
according to the manufacturer’s instructions. Hybridization
intensities were determined with an Axon GenePix 4200AL
scanner, and images were analyzed with Gene Pix software. The
expression data were processed and analyzed as described
previously [28]. In brief, the background-subtracted median
fluorescent values were normalized according to a LOWESS
normalization method, and Cy5/Cy3 ratios from replicate assays
were subjected to t-tests at a significance level of p,0.05 using
Figure 5. Elimination of the mosquito’s endogenous bacteria
reduces basal levels of immune gene expression and increases
the susceptibility to dengue virus infection. A. LB agar plates at
20 hours after plating homogenized and diluted septic gut (SG) and
whole mosquito (SW) from non-treated mosquitoes, and aseptic gut
(AG) and whole mosquito (AW) from antibiotic treated mosquitoes B.
fold change in the expression of selected immune genes in aseptic
mosquitoes compared to septic mosquitoes; C. virus infection levels in
aseptic and septic mosquitoes were measured and compared by plaque
assay in C6/36 cells * P,0.05 in Student’s t-test. D. Dengue virus
distribution and loads in septic and aseptic mosquito midguts assayed
through IFA. Error bar represents standard error. Primary data for the
real-time qPCR assays are presented in Table S2.
doi:10.1371/journal.ppat.1000098.g005
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replicate assays were averaged with the GEPAS microarray
preprocessing software prior to logarithm (base 2) transformation.
Self-self hybridizations have been used to determine the cut-off
value for the significance of gene regulation on these type of
microarrays to 0.8 in log2 scale, which corresponds to 1.74- fold
regulation. For genes with P,0.05, the average ratio was used as
the final fold change; for genes with P.0.05, the inconsistent
replicates (with distance to the median of replicate ratios large than
0.8) were removed, and only the value from a gene with at least
two replicates were further averaged. Toll and Imd signaling
pathways were built on the basis of a recent bioinformatics
prediction [17] with GeneMAPP2 software [39]. The latter was
also used for the generation of the expression datasets. The gene
database was created with the Ae. aegypti gene ontology by the
GeneMapp development team. Three independent biological
replicate assays were performed. Numeric microarray gene
expression data are presented in Tables S1 and S2.
Real-time qPCR assays
Real-time qPCR assays were conducted as previous described
[37]. Briefly, RNA samples were treated with Turbo DNase
(Ambion, Austin, Texas, United States) and reverse-transcribed
using Superscript III (Invitrogen, Carlsbad, California, United
States) with random hexamers. Real-time quantification was
performed using the QuantiTect SYBR Green PCR Kit (Qiagen)
and ABI Detection System ABI Prism 7000 (Applied Biosystems,
Foster City, California, United States). Three independent
biological replicates were conducted and all PCR reactions were
performed in triplicate. The ribosomal protein S7 gene was used
for normalization of cDNA templates. Primer sequences are listed
in Table S5. Numeric data for the real-time qPCR assays are
presented in Table S3.
Gene-silencing assays
RNA interference (RNAi)-based gene-silencing assays were
conducted according to standard methodology [34]: Approxi-
mately 69 gl dsRNAs (3 mg/ml) in water was injected into the
thorax of cold-anesthetized 4-day-old female mosquitoes using a
nano-injector as previously described (http://www.jove.com/
index/Details.stp?ID=230). Three to four days after injection
and validation of gene-specific silencing, mosquitoes were fed on a
DENV-2-supplemented blood meal. Dissection of mosquito
midguts, thoraxes, and heads were done on the seventh day
PBM. Each tissue was homogenized separately in the same
medium as used for C6/36 cells (MEM) and used for virus
titration. Three independent biological replicate assays were
performed for each gene. The following primers were used for
the synthesis of Cactus, Caspar and MyD88 dsRNA using the T7
megascript kit (Ambion): Cactus_F: TAATACGACTCACTA-
TAGGG CGAGTCAACAGAACCCGAGCAG, Cactus_R: TA-
ATACGACTCACTATAGGG TGGCCCGTCAGCACCGAA-
AG, Caspar_F: TAATACGACTCACTATAGGG GGAAGCA-
GATCGAGCCAAGCAG, Caspar_R: TAATACGACTCAC-
TATAGGG GCATTGAGCCGCCTGGTGTC, MyD88_F:
TAATACGACTCACTATAGGGGGCGATTGGTGGTTGT-
TATT, MyD88_R: TAATACGACTCACTATAGGGTTGA-
GCGCATTGCTAACATC,
DENV-2 virus titration
Virustitersinthetissuehomogenatesweremeasuredaspreviously
reported (http://www.jove.com/index/Details.stp?ID=220): The
virus-containing homogenates were serially diluted and inoculated
into C6/36 cells in 24-well plates. After incubation for 5 days at
32uC and 5% CO2, the plates were assayed for plaque formation by
peroxidase immunostaining, using mouse hyperimmune ascitic fluid
(MHIAF, specific for DENV-2) and a goat anti-mouse HRP
conjugate as the primary and secondary antibody, respectively.
Numeric PFU data are presented in Table S3.
Mosquito antibiotic treatment
After pupation, mosquitoes were transferred to a sterile cage
and provided a sterile 10% sucrose solution with 15 mg/ml
gentamicin, 10 units penicillin, and 10 mg streptomycin as a sugar
source. The removal of microbes was confirmed by colony-
forming unit assays prior to blood-feeding and after a surface
sterilization that involved vortexing in 70% ethanol and
subsequent rinsing in double-distilled sterile H2O. Each entire
mosquito was then homogenized in 100 ml autoclaved PBS and
plated on LB-agar, and the plates were checked for presence of
bacterial growth at 48 h post-inoculation.
Indirect immunofluorescence assays
These assays were performed according to a modification of a
previously established method [40]. The midguts from 7-day-old
mosquitoes were dissected in 1.0% paraformaldehyde in PBS.
After a 1-h incubation in 50 ml of 4.0% paraformaldehyde in a 96-
well plate, the midguts were washed three times with 100 ml PBS
for 1 min each; 100 ml of 10% goat serum was then added to the
antibody dilution buffer (0.1% TritonX-100 and 0.2% BSA in
PBS) and incubated overnight. The midguts were then incubated
with FITC-conjugated monoclonal antibody 2H2 at 37uC for 1 h.
The midguts were washed twice with PBS at room temperature for
1 h and then stained with Evans blue counter-stain (diluted 1:
100), placed onto slides, and covered with Bartel B 1029-45B
mounting medium and a coverslip. Preparations were examined
under a Nikon fluorescence microscope.
Accession numbers
The Entrez Gene ID for genes and proteins mentioned in the text
are 5565922 (Cactus), 5569526 (REL1A), 5578608 (Caspar),
5569427 (REL2), 5579094 (DEF), 5579377 (CEC), 5578028
(Attacin), 5565542 (Diptericin), 5579192 (GNBPB1), 5564897
(PGRGLC), 5564993 (Gambicin), 5569574 (MyD88), 5579458
(LYSC), 5576410 (Ikkg), 5565422 (GNBPA2), 5580019
(AAEL009645), 5572476 (AAEL009822), 5576330 (AAEL000393),
5576380 (DOME), 5573010 (SPZ5), 5578273 (TOLL1B), 5577966
(TOLL9A), 5576030 (TEP13), 5565197 (TEP15), 5572428 (TEP20).
5563609 (TEP22), 5568254 (FREP), 5577659 (CLIPB13B).
Supporting Information
Figure S1 A. The bacteria flora in the mosquito lumen does not
influence the viability of the dengue virus. Seven days old
antibiotic treated aseptic or non-treated septic mosquitoes were
fed with the same mixture of DENV-2 and blood. Two hour after
the blood meal, midguts were dissected and their content was
immediately diluted with 100 ul sterile PBS. Three replicates of
five guts each were collected. After a brief homogenization and
centrifugation, the supernatants were used to determine the virus
titer with the standard plaque assay. B. In vitro exposure of dengue
virus to midgut bacteria does not affect the virus viability.
Incubation of the dengue virus with either sterile PBS, bacteria
exposed supernatant or a bacteria suspension did not result in any
significant difference in virus viability. Ten midguts from seven
days old septic female mosquitoes were dissected and homoge-
nized in 100 ul sterile PBS prior to plating on a LB agar plate for
bacterial growth. Bacteria colonies were washed off the plate with
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centrifugation at 1,500 g the bacteria-free supernatant and the
bacteria pellet were collected. The bacteria pellet was re-
suspended into PBS to get the bacteria solution. Then, equal
amount of virus were incubated for 3 hrs at room temperature
with the bacteria, the bacteria free supernatant and the sterile PBS
prior to titer determination with plaques assay. Three replicates
were performed for each treatment.
Found at: doi:10.1371/journal.ppat.1000098.s001 (0.07 MB JPG)
Table S1 The functional groups of the total 432 genes that were
regulated by DENV-2 infection in the mosquito carcass at ten days
after an infected blood meal, compared to that of non-infected
blood fed control mosquitoes. Functional group abbreviations:
IMM, immunity; RED/STE, redox and oxidoreductive stress;
CSR, chemosensory reception; DIG, blood and sugar food
digestive; PROT, proteolysis; CYT/STR, cytoskeletal and
structural; TRP, transport; R/T/T, replication, transcription,
and translation; MET, metabolism; DIV, diverse functions; UNK,
unknown functions.
Found at: doi:10.1371/journal.ppat.1000098.s002 (0.38 MB
DOC)
Table S2 The functional groups of the total 63 genes that were
regulated by DENV-2 infection in the mosquito midgut at ten days
after an infected blood meal, compared to that of non-infected blood
fed control mosquitoes. Functional group abbreviations: IMM,
immunity; RED/STE, redox and oxidoreductive stress; CSR,
chemosensory reception; DIG, blood and sugar food digestive;
PROT, proteolysis; CYT/STR, cytoskeletal and structural; TRP,
transport; R/T/T, replication, transcription, and translation; MET,
metabolism; DIV, diverse functions; UNK, unknown functions.
Found at: doi:10.1371/journal.ppat.1000098.s003 (0.08 MB
DOC)
Table S3 Averaged data from three biological replicate real time
qPCR assays of the expression of defensin, cecropin, Cactus, and
Rel1in Cactus, and Cactus & Rel1 depleted mosquitoes (A) and in
Caspar, and Caspar & Rel2 depleted mosquitoes (B). C. Fold
change in the expression of selected immune genes in aseptic
mosquitoes compared to septic mosquitoes. S.E., standard error.
Found at: doi:10.1371/journal.ppat.1000098.s004 (0.06 MB
DOC)
Table S4 A. Averaged data from three independent biological
replicate plaque assays of the virus titer in the midguts of the
Cactus, Caspar, MYD88 and GFP dsRNA treated mosquitoes. B.
Results from three independent biological replicate plaque assays
of the virus titer in the midgut of antibiotic treated aseptic and
non-treated septic mosquitoes. S.E., standard error; S, significant;
NS, Non-significant.
Found at: doi:10.1371/journal.ppat.1000098.s005 (0.04 MB
DOC)
Table S5 The prime sequences used for the real-time qPCR
assays.
Found at: doi:10.1371/journal.ppat.1000098.s006 (0.04 MB
DOC)
Table S6 The expression data of all the genes that are shown in
the hierarchical cluster matrix (Fig. 3C).
Found at: doi:10.1371/journal.ppat.1000098.s007 (0.30 MB
DOC)
Text S1 This section refers to other dengue infection responsive
genes.
Found at: doi:10.1371/journal.ppat.1000098.s008 (0.05 MB
DOC)
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